Stifel Nicolaus reiterates its Buy rating on Stryker SYK and raises its price target to $61 from $59 on increased visibility into 2012.
Stifel Nicolaus says, "Adjusting for challenging 4Q2011 YoY growth comparisons, Stryker posted flat sequential revenue growth (+11% CC). Traction for new products and acquired businesses remain
key drivers in driving momentum for Stryker. This is despite end-markets that continue to be challenged across all of Stryker's businesses in recon, MedSurg and spine; this also includes one-less selling day for recon in 4Q2011. Going into 2012, YoY growth comparisons only become easier. And, we contend management's 2012 guidance is modest as organic revenue growth is expected to be 2%-5% growth (vs. 4% organic revenue growth in 2011)."
SYK closed at $52.94 a share on
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in